TNF

肿瘤坏死因子

常用释义

abbr. 无溢出转移（Transfer on No Overflow）

扩展信息

肿瘤坏死因子(tumor necrosis factor)

肿瘤坏死因子（TNF）是一种重要的调节机体免疫功能和代谢过程的多功能细胞因子，可分两类，TNF-α(又称恶液质素)是由致 …

细胞因子如肿瘤坏死因子

　　细胞因子如肿瘤坏死因子（TNF）、白细胞介素（IL-1）-1和IL-6等在严重细菌感染的病人中常有升高，但是缺乏特异性，通常 …

肿瘤坏死因数(Tumour Necrosis Factor)

其中13例病人的肿瘤坏死因数（TNF）降低；P-24 抗体阴性或弱阳性。尽管停止高压氧治疗1个月，有4例病人疲劳程度恢复到 …

细胞因子肿瘤坏死因子

其中对细胞因子肿瘤坏死因子（TNF），细胞介素-1（IL-1）及其受体拮抗剂（IL-1ra），白细胞介素-10（IL-10）的深入研究， …

肿瘤坏死因子测定

肿瘤坏死因子测定(TNF-a)体检结果：26.80,比参考值相关科室最新问答回复区中医　精神心理　用药相关　症状咨询　　肿瘤科　精华 …

例句

The FDA also reviewed 69 cases of psoriasis and said it found a possible link between the skin disorder and use of TNF blockers.

FDA 也检查了 69 例牛皮癣，称皮肤病症和 TNF 拮抗剂之间可能存在某种的联系。

B cell activating factor (BAFF) is one of the TNF family member, regulates the survival and maturation of B lymphocyte.

B 细胞激活因子（BAFF）是调节 B 淋巴细胞存活和成熟的细胞因子，属于 TNF 家族成员。

And one of the things were looking at is specific phosphodiesterase inhibitors to block the endotoxin or LPS-stimulable TNF.

目前正在做的一项工作是用特异性磷酸二酯酶抑制剂来阻断内毒素或 LPS 脂多糖刺激 TNF 的产生。

The FDA said it had reviewed 147 reports of leukemia in adults and children using TNF blockers, including 30 deaths.

FDA 称已经检查了 147 例成年和儿童使用 TNF 拮抗剂的白血病报告，其中 30 例死亡。

The second report links susceptibility to SLE with increased expression of a gene in the tumor necrosis factor (TNF) superfamily .

第二项报告将 SLE 易感性与肿瘤坏死因子（TNF）超家族基因的过分表达联系起来。

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor (TNF) superfamily .

TRAIL 是肿瘤坏死因子超家族成员，广泛表达于多种组织细胞。

Patients who develop a fungal infection may be advised to stop the TNF blocker until they recover.

受到真菌感染的患者可能会被建议在真菌疾病康复前中止使用 TNF 阻滞剂。

TNFR-specific effects in HF should be considered when therapeutic anti-TNF strategies are developed.

开发抗 TNF 的治疗策略时需要考虑 HF 过程中 TNFR-特异性的作用。

The FDA also has received reports of cases of coccidioidomycosis and blastomycosis, including deaths, in patients treated with TNF blockers.

还收到一些使用 TNF 阻滞剂导致球孢子病和芽生菌病的报告，甚至还有死亡病例。

Among the three anti-TNF-alpha agents, this phenomenon has been studied mainly in patients using infliximab, especially in RA and CD.

在三种 TNF 拮抗剂中，免疫原性相关研究主要见于英夫利昔治疗的病人中，尤其是 RA 和 CD。

Remicade belongs to a class of drugs called tumor necrosis factor (TNF) blockers.

Remicade 属于被称为肿瘤坏死因子（TNF）阻断剂类药物。

Cathepsin B actively participates in hepatocellular apoptosis, e. g. after exposure of hepatocytes to TNF .

组织蛋白酶 B 积极参与肝细胞凋亡，肝细胞后，肿瘤坏死因子，例如接触。

Results. Typical apoptotic changes of the cell nuclei were observed in the DRG after application of TNF.

结果：应用 TNF 后，我们观察到在 DGR 内髓核细胞典型的调亡改变。

Research Design and Methods: RIP-TNF-NOD mice were crossed to B cell deficient NOD mice and diabetes development monitored.

设计及方法：RIP-TNF-NOD 小鼠与 B 细胞缺陷非肥胖糖尿病（NOD）小鼠交配获得子代，并且监测糖尿病病程发展。

The scientists showed that all three drugs inhibited the production of TNF, which reduced inflammation in these cells.

科学家们发现，所有这三种药物都能抑制 TNF 的产生，减轻这些细胞的炎症情况。

Death receptors belong to the tumour necrosis factor (TNF) receptor superfamily.

死亡受体属于肿瘤坏死因子（TNF）受体超家族。

thus , we also investigated the effects of elf - mf exposure on clustering of egf , tnf receptors in cultured cells.

因此本文又进一步探索了极低频磁场对细胞膜受体聚簇的作用。

inflammatory and remodeling responses in HF that are TNF-receptor (TNFR) specific.

导心肌炎症和重塑反应，这些反应具有 TNF 受体（TNFR）特异性。

Immunosuppressive drug addiction can reduce the induction of anti-TNF-alpha antibodies.

加用免疫抑制剂可以减少抗 TNF 拮抗剂抗体的产生。

Objective: To explore the changes of thyroid hormone and tumor necrosis factor(TNF) in severe patients.

目的：探讨危重患者甲状腺激素与肿瘤坏死因子的动态变化。

We identified the generation of amino-terminally truncated versions of DBC-1 during tumor necrosis factor (TNF)--mediated apoptosis.

研究者证实，在肿瘤坏死因子（TNF）介导的凋亡过程中，出现 DBC-1 的氨基端截断倒位的形成。

Conclusion: TNF may play an promoting role in eccentric left ventricular hypertrophy.

结论：TNF 促进了左室构型向离心性肥厚的发展。

Expression of TNF-[alpha] was compared in rats with crush injury, with and without sympathectomy.

比较受挤压伤的大鼠在接受和不接受交感神经切除时 TNF-α 的表达情况。

Etanercept is a recombinant soluble TNF-alpha receptor fusion protein that binds to TNF-alpha.

依那西普是一个重组可溶性肿瘤坏死因子 -α 受体融合蛋白，它可结合肿瘤坏死因子 -α。

There are now a few uncontrolled studies supporting the use of TNF inhibitors in patients with active disease.

目前，已有几个无对照组的临床研究支持使用 TNF 抑制剂治疗活动性病人。

更新时间：2025-06-21 02:37